New Topoisomerase II Inhibitor Study

This Merck study was published in Cell and showcases the use of our E. coli DNA Gyrase and Topo IV assay protocols in identifying a new class of Topo II inhibitor. The following type II topoisomerases were provided for the study by TopoGEN: E. coli DNA Gyrase, Topoisomerase IV. The following plasmids were also provided by TopoGEN: pBR322, kDNA.